Tucson, AZ5 Active Studies

Multiple Myeloma Clinical Trials in Tucson, AZ

Find 5 actively recruiting multiple myeloma clinical trials in Tucson, AZ. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
2,959
Enrolling

Recruiting Multiple Myeloma Studies in Tucson

RecruitingTucson, AZNCT04566328

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethason...

1,450 participants
ECOG-ACRIN Cancer Research Group
View Study Details
RecruitingTucson, AZNCT05535946

ABTECT - Maintenance

This is a multicenter, randomized, placebo-controlled study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as maintenance therapy in subjects with m...

1,050 participants
Abivax S.A.
View Study Details
RecruitingTucson, AZNCT05028348

A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma

This phase 3 randomized, open-label multicenter trial will compare the efficacy, safety and the impact on health-related quality of life (HR-QoL) of SPd versus EloPd in pomalidomide-naïve patients wit...

222 participants
Stichting European Myeloma Network
View Study Details
RecruitingTucson, AZNCT07032662

IMVT-1402 in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

This is a Phase 2b study to evaluate the efficacy and safety of IMVT-1402 in adults with CIDP....

162 participants
Immunovant Sciences GmbH
View Study Details
RecruitingTucson, AZNCT05972135

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

This is a phase II study to evaluate the outpatient administration of Teclistamab or Talquetamab in Multiple Myeloma patients...

75 participants
SCRI Development Innovations, LLC
View Study Details

About Multiple Myeloma Clinical Trials in Tucson

Multiple myeloma is a cancer of plasma cells in the bone marrow that produce abnormal antibodies. It can cause bone damage, kidney problems, and immune deficiency. Treatments have advanced significantly with proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapy.

There are currently 5 multiple myeloma clinical trials recruiting participants in Tucson, AZ. These studies are seeking a combined 2,959 participants. Research is being sponsored by ECOG-ACRIN Cancer Research Group, Abivax S.A., Stichting European Myeloma Network and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Myeloma Clinical Trials in Tucson — FAQ

Are there multiple myeloma clinical trials in Tucson?

Yes, there are 5 multiple myeloma clinical trials currently recruiting in Tucson, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Tucson?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you about next steps.

Are clinical trials in Tucson free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tucson studies also compensate for your time and travel.

What multiple myeloma treatments are being tested?

The 5 active trials in Tucson are testing new therapies including novel drugs, biologics, and treatment approaches for multiple myeloma.

Data updated March 2, 2026 from ClinicalTrials.gov